IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: preliminary findings

被引：0
|
作者：
M. Gelati
E. Lamperti
A. Dufour
E. Corsini
E. Venegoni
C. Milanese
A. Nespolo
A. Salmaggi
机构：
[1] Istituto Nazionale Neurologico “C. Besta”,Servizio di Neurologia
[2] Presidio Ospedaliero di Magenta,Medicina I, Azienda USSL 35
来源：
The Italian Journal of Neurological Sciences | 1997年 / 18卷
关键词：
IL-10; SM; SLE; Steroids;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
IL-10 is a cytokine with suppressive effects on (auto) antigen presentation an T-cell-mediated immune reactions, but is also capable of stimulating polyclonal IgG synthesis. Recent evidence suggests its involvement in multiple sclerosis (MS) and systemic lupus erythematosus (SLE).
引用
收藏
页码：191 / 194
页数：3
相关论文
共 50 条
  • [21] TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls
    Farrokhi, Mehrdad
    Etemadifar, Masoud
    Alavi, Maryam Sadat Jafary
    Zarkesh-Esfahani, Sayyed Hamid
    Behjati, Mohaddeseh
    Rezaei, Ali
    Amani-Beni, Ali
    IMMUNOLOGICAL INVESTIGATIONS, 2015, 44 (06) : 590 - 601
  • [22] Whole blood production of interleukin-10 (IL-10) and IL-10 plasma levels in ESRD patients.
    Lonnemann, G
    Eberhard, O
    Linnenweber, S
    Koch, KM
    Dinarello, CA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1207 - A1207
  • [23] Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis
    Nakashima, I
    Fujihara, K
    Misu, T
    Okita, N
    Takase, S
    Itoyama, Y
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 111 (1-2) : 64 - 67
  • [24] IL-12 INHIBITS THE PRODUCTION OF IL-10 IN PATIENTS WITH SJOGREN SYNDROME
    Yao, G.
    Chen, W.
    Tang, X.
    Feng, X.
    Sun, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 950 - 950
  • [25] Interferon-β inhibits IL-10 production in activated human monocytes and stimulates IL-10 in T cells:: Implications for multiple sclerosis therapy
    Hamamcioglu, K
    Reder, AT
    ANNALS OF NEUROLOGY, 2003, 54 : S63 - S63
  • [26] Clinical implications of IL-10 promoter polymorphisms on disease susceptibility in Indian SLE patients
    Umare, Vinod
    Pradhan, Vandana
    Dadheech, Sneha
    Rajadhyaksha, Anjali
    Ghosh, Kanjaksha
    Nadkarni, Anita
    LUPUS, 2020, 29 (06) : 587 - 598
  • [27] Gait Mechanics Are Different Between Healthy Controls and Patients With Multiple Sclerosis
    Huisinga, Jessie M.
    Schmid, Kendra K.
    Filipi, Mary L.
    Stergiou, Nicholas
    JOURNAL OF APPLIED BIOMECHANICS, 2013, 29 (03) : 303 - 311
  • [28] Assessment of difference in chronotypes between patients with multiple sclerosis and healthy controls
    Mioc, M.
    Barun, B.
    Habek, M.
    Barusic, A. K.
    Bach, I.
    JOURNAL OF SLEEP RESEARCH, 2014, 23 : 172 - 172
  • [29] IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE)
    Bussolati, B
    Rollino, C
    Mariano, F
    Quarello, F
    Camussi, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (03): : 471 - 476
  • [30] Gait mechanics are different between healthy controls and patients with multiple sclerosis
    Huisinga, J.M., 1600, Human Kinetics Publishers Inc. (29):
12345